Tai Yin Yang
Director/Board Member bei KODIAK SCIENCES INC.
Vermögen: - $ am 31.03.2024
Profil
Tai Yin Yang is currently serving as an Independent Director at Kodiak Sciences, Inc., Kronos Bio, Inc., and Brii Biosciences Ltd.
(China).
She is also a Member of the American Chemical Society, the National Academy of Engineering, the American Association of Pharmaceutical Scientists, and the Drug Information Association.
Additionally, she serves as a Scientific Advisor at Sionna Therapeutics, Inc. In the past, she worked as a Director-Analytical Chemistry at Syntex Corp.
and as the EVP-Pharmaceutical Development & Manufacturing at Gilead Sciences, Inc. She holds a doctorate degree from the University of Southern California and an undergraduate degree from National Taiwan University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
KRONOS BIO INC
-.--% | 22.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
KODIAK SCIENCES, INC.
-.--% | 30.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Tai Yin Yang
Unternehmen | Position | Beginn |
---|---|---|
KODIAK SCIENCES INC. | Director/Board Member | 17.12.2019 |
KRONOS BIO, INC. | Director/Board Member | 25.03.2021 |
BRII BIOSCIENCES LIMITED | Director/Board Member | 01.09.2022 |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Corporate Officer/Principal | - |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Corporate Officer/Principal | - |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The private company is based in Washington. | Corporate Officer/Principal | 01.01.2022 |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Tai Yin Yang
Unternehmen | Position | Ende |
---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 18.07.2022 |
░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Tai Yin Yang
University of Southern California | Doctorate Degree |
National Taiwan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
KODIAK SCIENCES INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
BRII BIOSCIENCES LIMITED | Commercial Services |
Private Unternehmen | 6 |
---|---|
Syntex Corp. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The private company is based in Washington. | Commercial Services |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Health Services |